Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus

European Journal of Clinical Investigation

Volumn 33, Issue 4, 2003, Pages 301-306

  Tan, K C B ^a,b   Shiu, S W M ^a   Wong, Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Cholesteryl ester transfer protein; Dense LDL; Phospholipid transfer protein; Small; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY GRADIENT CENTRIFUGATION; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOMETRY; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; DIABETES MELLITUS, TYPE 2; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 0037395622     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01132.x     Document Type: Article

References (38)

1. Tall AR, Jiang X, Luo Y, Silver D. 1999 George Lyman Duff memorial lecture lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:1185-8.
2. Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 2001;155:269-81.
3. Tu AY, Paigen B, Wolfbauer G, Cheung MC, Kennedy H, Chen H et al. Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice. Int J Clin Lab Res 1999;29:14-21.
4. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999;103:907-14.
5. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gent T, van den Berg P et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000;20:1082-8.
6. Inazu A, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 2000;11:389-96.
7. Packard CJ. LDL subfractions and atherogenicity an hypothesis from the University of Glasgow. Curr Med Res Opin 1996;13:379-90.
8. Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest 1996;97:2687-8.
9. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
10. Moriyama Y, Okamura T, Inazu A, Doi M, Iso H, Mouri Y et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med 1998;27:659-67.
11. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;364:73-5.
12. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071-4.
13. Riemens S, van Tol A, Sluiter W, Dullaart R. Elevated plasma cholesteryl ester transfer in NIDDM. relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998;140:71-9.
14. Vakkilainen J, Jauhiainen M, Ylitalo K, Nuotio IO, Viikari JS, Ehnholm C et al. LDL particle size in familial combined hyperlipidemia. Effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J Lipid Res 2002;43:598-603.
15. Tan KC, Shiu SW, Chu BY. Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1999;145:273-8.
16. Colhoun HM, Scheek LM, Rubens MB, Van Gent T, Underwood SR, Fuller JH et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001;50:652-9.
17. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia 1998;41:929-34.
18. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L et al. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 1999;19:266-75.
19. Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995;113:273-87.
20. Lagrost L, Athias A, Gambert P, Lallemant C. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res 1994;35:825-35.
21. Tahvanainen E, Jauhiainen M, Funke H, Vartiainen E, Sundvall J, Ehnholm C. Serum phospholipid transfer protein activity and genetic variation of the PLTP gene. Atherosclerosis 1999;146:107-15.
22. Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994;14:1581-5.
23. Liinamaa MJ, Hannuksela ML, Kesaniemi YA, Savolainen MJ. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 1997;17:2940-7.
24. Riemens SC, Van Tol A, Sluiter WJ, Dullaart RP. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. J Lipid Res 1999;40:1459-66.
25. Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A et al. Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis 1999;142:395-402.
26. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Rotter MC. Accelerated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis 1993;104:69-77.
27. Elchebly M, Porokhov B, Pulcini T, Berthezene F, Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis 1996;123:93-101.
28. Dullaart RP, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994;24:188-94.
29. Murdoch SJ, Carr MC, Hokanson JE, Brunzell JD, Albers JJ. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res 2000;41:237-44.
30. Kaser S, Sandhofer A, Foger B, Ebenbichler CF, Igelseder B, Malaimare L et al. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia 2001;44:1111-7.
31. Van Tol A, Ligtenberg JJ, Riemens SC, van Haeften TW, Reitsma WD, Dullaart RP. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest 1997;57:147-57.
32. He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes 2001;25:748-52.
33. Tu AY, Albers JJ. Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 2001;50:1851-6.
34. Watson TD, Caslake MJ, Freeman DJ, Griffin BA, Hinnie J, Packard CJ et al. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb 1994;14:902-10.
35. Cheung MC, Knopp RH, Retzlaff B, Kennedy H, Wolfbauer G, Albers JJ. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL. impact of gender and adiposity. Biochim Biophys Acta 2002;1587:53-9.
36. Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 1988;29:1593-602.
37. Foger B, Luef G, Ritsch A, Schmidauer C, Doblinger A, Lechleimer M et al. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 1995;73:369-72.
38. Goto A, Sasai K, Suzuki S, Fukutomi T, Ito S, Matsushita T et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis 2001;159:153-63.